A transformative leap in medical technology may soon change how we detect sepsis and other inflammatory conditions. Researchers at UC San Diego have unveiled a non-invasive device that monitors involuntary nervous system activity, providing critical, real-time data that can signal impending sepsis. This condition can significantly increase the risk of death if not promptly addressed.
The research team, as detailed in a UC San Diego report, demonstrated their technology's ability to measure autonomic neural activity—signals from the human vagus and carotid sinus nerves—non-invasively. The breakthrough could be a game-changer in clinical settings, where early detection of inflammatory responses is crucial yet challenging. The electronics designed to achieve this are integrated into a flexible, adhesive electrode array, a departure from the invasive techniques traditionally used.
In a publication dated July 29, 2024, Nature Communications Biology highlighted the groundbreaking findings of this study. Imanuel Lerman, head of the Lerman Lab of UC San Diego's Qualcomm Institute and a pivotal figure in this research, said, "The device is poised to provide an early diagnostic marker of pathogen infection, or inflammation from a pathological process," according to UC San Diego.
The team tested the device, employing a method labeled "magnetoneurography," on nine adult subjects by inducing a hyperinflammatory state similar to that caused by blood infections. Their findings included changes in nerve activity beneath the right ear in response to induced inflammation, which correlated with increased levels of specific inflammation markers in the patient's blood.
Supporting Lerman and Bu's findings is their technology's ability not just to detect but potentially anticipate the body's impending hyperimmune or immunoparalysis response to infection. These two conditions heighten the risk of sepsis-related complications. Such advancements can not only offer a significant edge in treating sepsis. Still, they may also be employed for assessing the effectiveness of anti-inflammatory treatments related to PTSD and other mental health ailments. The multidisciplinary research effort drew upon resources and experts from several institutions, including Sandia National Laboratories, the University of Wisconsin-Madison, Stanford University, and the VA Center for Stress and Mental Health, with funding from BARDA and private sources.
